Advertisement
Advertisement

OMDA

O

Omada Health, Inc. Common Stock

11.64
USD
Sponsored
-0.35
-2.89%
Feb 06, 15:59 UTC -5
Closed
exchange

After-Market

11.77

+0.13
+1.08%

OMDA Earnings Reports

Positive Surprise Ratio

OMDA beat 2 of 2 last estimates.

100%

Next Report

Date of Next Report
Mar 05, 2026
Estimate for Q4 25 (Revenue/ EPS)
$71.06M
/
-$0.05
Implied change from Q3 25 (Revenue/ EPS)
+4.46%
/
-16.67%
Implied change from Q4 24 (Revenue/ EPS)
--
/
--

Omada Health, Inc. Common Stock earnings per share and revenue

On Nov 06, 2025, OMDA reported earnings of -0.06 USD per share (EPS) for Q3 25, beating the estimate of -0.07 USD, resulting in a 22.88% surprise. Revenue reached 68.03 million, compared to an expected 62.24 million, with a 9.30% difference. The market reacted with a -7.13% price change (close before vs. close after earnings).
Looking ahead to Q4 25, -- analysts forecast an EPS of -0.05 USD, with revenue projected to reach 71.06 million USD, implying an decrease of -16.67% EPS, and increase of 4.46% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
InnovAge Holding Corp. Common Stock
Report Date
Feb 03, 2026 For Q2 26
Estimate
$0.04
Actual
$0.08
Surprise
+96.08%
logo
Embecta Corp. Common Stock
Report Date
Feb 05, 2026 For Q1 26
Estimate
$0.68
Actual
$0.71
Surprise
+3.89%
logo
Danaher Corporation
Report Date
Jan 28, 2026 For Q4 25
Estimate
$2.17
Actual
$2.23
Surprise
+2.56%
logo
HCA Healthcare, Inc.
Report Date
Jan 27, 2026 For Q4 25
Estimate
$7.53
Actual
$8.14
Surprise
+8.05%
logo
Elevance Health, Inc.
Report Date
Jan 28, 2026 For Q4 25
Estimate
$3.12
Actual
$3.33
Surprise
+6.46%
logo
Cencora, Inc.
Report Date
Feb 04, 2026 For Q1 26
Estimate
$4.07
Actual
$4.08
Surprise
+0.16%
logo
Revvity, Inc.
Report Date
Feb 02, 2026 For Q4 25
Estimate
$1.58
Actual
$1.70
Surprise
+7.45%
FAQ
For Q3 2025, Omada Health, Inc. Common Stock reported EPS of -$0.06, beating estimates by 22.88%, and revenue of $68.03M, 9.3% above expectations.
The stock price moved down -7.13%, changed from $21.87 before the earnings release to $20.31 the day after.
The next earning report is scheduled for Mar 05, 2026.
Based on -- analysts, Omada Health, Inc. Common Stock is expected to report EPS of -$0.05 and revenue of $71.06M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement